Progesterone altering drug could reduce risk of aggressive breast cancer
17 June 2022
New research found that existing drugs that modify the effect of the hormone progesterone could reduce the risk of aggressive 鈥榯riple negative鈥� breast cancer in women by altering the BRCA1 gene. Lead author Professor Martin Widschwendter (UCL EGA Institute for Women鈥檚 Health).
Close
